Latest European patent oppositions filed by Dr. Schon, Neymeyr & Partner Patentanwalte Mbb
Patent Number | Title | Applicant | Opposition Date |
---|---|---|---|
EP3626270 | New Use | NOVARTIS AG | 2024-07-10 |
EP2508188 | Pharmaceutical Formulations Containing Dapagliflozin Propylene Glycol Hydrate | BRISTOL-MYERS SQUIBB COMPANY | 2024-02-09 |
EP3294283 | Sacubitril-Valsartan Dosage Regimen For Treating Heart Failure | NOVARTIS AG | 2023-11-30 |
EP3067043 | Pharmaceutical Compositions Based On Superstructures Of Angiotensin Receptor Antagonist/Blocker (Arb) And Neutral Endopeptidase (Nep) Inhibitor | NOVARTIS AG | 2023-08-24 |
EP3770046 | Driverless Transport System | MAGNA STEYR FAHRZEUGTECHNIK AG & CO KG | 2023-06-06 |
EP3100064 | Device And Method For Detecting Errors In Machines | KHS GMBH | 2023-05-17 |
EP3448416 | Semaglutide In Cardiovascular Conditions | NOVO NORDISK A/S | 2023-05-10 |
EP2653873 | Compositions And Uses For Treating Multiple Sclerosis | BIOGEN MA INC. | 2023-04-20 |
EP3540547 | Method For Maintenance Of An Automated Conveyor System And Conveyor System | GEBHARDT FÖRDERTECHNIK GMBH | 2023-04-19 |
EP2959894 | S1P Receptor Modulators For Treating Multiple Sclerosis | NOVARTIS AG | 2023-01-23 |
Top clients of Dr. Schon, Neymeyr & Partner Patentanwalte Mbb filing patent oppositions